Presence of Functional Cytochrome P–450 on Isolated Rat Hepatocyte Plasma Membrane
Open Access
- 1 May 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 11 (5) , 850-858
- https://doi.org/10.1002/hep.1840110521
Abstract
Antibodies against cytochrome P–450 are found in some children with autoimmune hepatitis (antiliver/kidney microsome) and in patients with ticrynafen hepatitis (antiliver/kidney microsome2). For an immune reaction against cytochrome P–450 to possibly destroy the hepatocytes, one must assume that cytochrome P–450 is present on the plasma membrane surface of hepatocytes. In a first series of experiments, plasma membranes were prepared with a technique based on the electrostatic attachment of isolated hepatocytes to polyethyleneimine–coated beads. After vortexing, beads were coated with a very pure plasma membrane fraction. Microsomal contamination, judged from the specific activities of glucose–6–phosphatase or NADH–cytochrome c reductase, was less than 1%. Nevertheless, the specific content (permilligram of protein) of CO–binding cytochrome P–450 was 20% of that in microsomes; the specific benzo (a)pyrene hydroxylase activity was 25%, and ethoxycoumarin deethylase 11%, Immunoblots showed the presence of cytochromes P–450 UT–A, UT–H, PB–B, ISF–G and PCN–E, the last three isoenzymes being inducible by, respectively, phenobarbital, 3–methylcholanthrene and dexamethasone. In a second series of experiments, nonpermeabilized isolated hepatocytes from untreated rats were incubated with anticytochrome P–450 antibodies. Immunfluorescence and immunoperoxidase staining confirmed the presence of cytochromes P–450 UT–A, PB–B and ISF–G on the membrane. In a last series of experiments, human antiliver kidney microsomal1 antibodies were found to react specifically with rat liver plasma membrane cytochrome P–450 UT–H (IID subfamily). We conclude that several cytochrome P–450 isoenzymes are present, active and inducible on the plasma membrane surface of hepatocytes. It is therefore conceivable that immunization against plasma membrane cytochrome P–450 might lead to the immunological destruction of hepatocytes in some patients.(HEPATOLGOY 1990; 11: 850–858.)This publication has 45 references indexed in Scilit:
- Anti-liver kidney microsome antibody type 1 recognizes human cytochrome P450 db1Biochemical and Biophysical Research Communications, 1989
- Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.Journal of Clinical Investigation, 1989
- A human cytochrome P-450 is recognized by anti-liver/kidney microsome antibodies in autoimmune chronic hepatitisBiochemical and Biophysical Research Communications, 1989
- The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal LociDNA, 1989
- Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.Proceedings of the National Academy of Sciences, 1988
- Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily.The Journal of Experimental Medicine, 1988
- Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiencyBiochemistry, 1987
- Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.Proceedings of the National Academy of Sciences, 1987
- Enzymatic activation of chemicals to toxic metabolitesCRC Critical Reviews in Toxicology, 1985
- Ticrynafen-Associated Hepatic Injury: Analysis of 340 CasesHepatology, 1984